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Background: Although new digital pathology tools have improved the positive cell quantification, there is a het-
erogeneity of the quantification methods in the literature. The aim of this study was to evaluate and propose a 
novel dendritic cells quantification method in squamous cell carcinoma comparing it with a conventional quanti-
fication method.
Material and Methods: Twenty-six squamous cell carcinomas HIV-positive cases affecting the oropharynx, lips 
and oral cavity were selected. Immunohistochemistry for CD1a, CD83, and CD207 was performed. The im-
munohistochemical stains were evaluated by automated examination using a positive pixel count algorithm. A 
conventional quantification method (unspecific area method; UA) and a novel method (specific area method; SA) 
were performed obtaining the corresponding density of positive dendritic cells for the intratumoral and peritu-
moral regions. The Mann-Whitney U test was used to verify the influence of the quantification methods on the 
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Introduction
The implementation of combined antiretroviral thera-
py (cART) has increased the life expectancy of HIV-
positive patients. However, new clinical challenges are 
being associated with HIV-positive patients such as 
the development of non-AIDS defining malignancies 
(1-6). Therefore, the incidence of head and neck cancer 
(HNC) has markedly increased since the widespread 
use of cART (1,7-11). During the multistep carcinogen-
esis events, changes in host immunological factors have 
been observed; thus, studying these complex interac-
tions is crucial for a better understanding of such ma-
lignancies (12).
Dendritic cells (DCs) have a central role in the regula-
tion of immunological responses, including antitumour 
immunity. DCs constitute a heterogeneous population 
of cells, where the immature cells have high phago-
cytic activity and the mature cells have high cytokine-
producing capacity, conditions that maintain a balance 
between innate and adaptive immunity (13). The major 
DCs population in the mucosa epithelium are the Lang-
erhans cells (LCs). LCs may have important roles in the 
course of an HIV infection, including the probable ini-
tial uptake of HIV transmission to the lymph nodes and 
subsequent transfer to T cells (14). Furthermore, LCs 
migration inhibition caused by tumor-derived factors 
prevents LCs from promoting antitumoral immunity 
(15-17).
Previous studies have shown the low density of LCs in 
squamous cell carcinoma (SCC) of the skin (18), uter-
ine cervix (19), and anal mucosa (20). Although the re-
lationship among CD4+ T (T helper cells) cell counts, 
HIV viral load, and LCs density remains unclear (21), 
these studies suggest that immunological changes as-
sociated with HIV infection are predisposing factors to 
the development of SCC. Once there are no studies that 
investigate DCs in HNC in HIV-positive patients, the 
quantification of these cells is prime for a better under-
standing of this subject and may reveal important data 
for future steps. However, a great variability of values 
has been noticed in studies investigating the density of 
DCs (19,22-25), which complicate the use of published 
data as reference for new studies.
New digital pathology tools have improved the positive 
cell quantification process. The automated examination 
involving the positive pixel count algorithm is replacing 
the old manual methods since it allows to explore the 
association of different digital tools. However, the con-
ventional methods for quantifying specific cells in SCC 
do not consider the variability of the tumour morpho-
logical presentation or the amount of inflammation in 
the evaluated selected areas. Normally, a 1-mm² hotspot 
area of a well or moderately differentiated SCC has a dif-
ferent amount of tumour when compared with a poorly 
differentiated SCC area. Similar bias can occur in re-
gions with different amount of inflammation, regarding 
the evaluation of immune cell as DCs. The conventional 
methods quantify cells in the total hotspot areas, so non-
target areas, such as fibrosis, can be wrongly considered. 
Hence, the reproducibility of the studies is affected.
Thus, the aim of the present study was to evaluate a 
novel DCs quantification method in SCC, comparing it 
with a conventional method. The research null hypoth-
esis is that a specific area quantification method does 
not influence the positive cell counting results.
Material and Methods
Paraffin-embedded tissue samples from 26 SCCs HIV-
positive cases affecting the oropharynx, lips and oral 
cavity were selected from the Departments of Pathol-
ogy at Instituto do Câncer do Estado de São Paulo, 
Brazil, and the University of Pretoria, Pretoria, South 
Africa. The pathological reports were examined for 
demographic data. The histological grade was revised 
by two oral pathologists according to a classification 
proposed by the World Health Organization (26) while 
the amount of inflammation was evaluated in the peri-
tumoral areas.
Immunohistochemistry was performed on 3 μm for-
malin-fixed paraffin-embedded tissue sections using 
the Ventana Benchmark GX automated system (Ven-
tana Medical Systems Inc., Tucson, Arizona). Epitope 
retrieval to demonstrate CD1a (T-cell surface glyco-
protein CD1a; EP3622), CD83 (CD83 antigen; 1H4b) 
and CD207 (C-type lectin domain family 4 member K; 
12D6) expression was performed in high pH retrieval 
positive cell counting according to the evaluated regions. Data were subjected to the ANOVA and Student’s t-test to 
verify the influence of the tumour location, stage, histological grade, and amount of inflammation on the dendritic 
cells density counting.
Results: The cell quantification method affected the dendritic cells counting independently of the evaluated region 
(P-value <0.05). Significant differences between methods were also observed according to the tumour features evalu-
ations. 
Conclusions: The positive cell quantification method influences the dendritic cells density results. Unlike the con-
ventional method (UA method), the novel SA method avoids non-target areas included in the hotspots improving the 
reliability and reproducibility of the density cell quantification.
 Key words: Cell counts, immunohistochemistry, dendritic cells, HIV, head and neck neoplasms.
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buffer for 56 min for CD1a and CD83, and in low pH 
retrieval buffer for 48 min for CD207. The incubation 
was performed with Cell Marque monoclonal rabbit 
antihuman RTU CD1a (Cell Marque, CA, USA; no di-
lution required) for the CD1a, a 1:40 Novocastra mono-
clonal mouse antihuman CD83 (Leica BioSystems Ltd., 
Newcastle, UK) for the CD83, and a 1:50 Novocastra 
monoclonal mouse antihuman Langerin (Leica Bio-
Systems Ltd., Newcastle, UK) for the Langerin. The 
antibodies were detected with the Ventana OptiView 
DAB Detection System. Sections were counterstained 
in Haematoxylin, dehydrated and mounted with perma-
nent mounting media. Positive controls were included 
in all reactions in accordance with the manufacturer’s 
protocols. The selection of the antibodies was based on 
their well-established biological properties and previ-
ous investigations in different neoplasms
The immunohistochemical stains were evaluated by 
automated examination based on a previous methodol-
ogy (25). All slides were scanned with the Scan Scope 
Aperio System (Aperio, Vista, CA, USA) obtaining a 
high-quality resolution digital image. The automated 
staining intensity was quantified with the IMAGES-
COPE software (Aperio) using a membrane positive 
pixel count algorithm. The staining intensity was clas-
sified as strongly positive (red), positive (orange), weak-
ly positive (yellow), or negative (blue). For the proper 
quantification and to avoid background staining, only 
the strongly positive results were considered.
For each case, the conventional quantification method 
(unspecific area method; UA) and the new method 
(specific area method; SA) were applied. Initially, four 
1-mm² hotspots were selected for both intratumoral 
and peritumoral areas. For the UA method, the posi-
tive pixel count software was performed on the total 
of each 1-mm² hotspot obtaining an average of positive 
DCs (number of cells/mm²) for each case (average of all 
hotspots). For the SA method, the exact tumour (intratu-
moral analyses) or inflammation (peritumoral analyses) 
areas inside of each 1-mm² hotspot were demarcated 
and the positive pixel count software was performed 
only on these specified areas (Fig. 1).
Fig. 1: Immunohistochemical detection of CD1a+ dendritic cells in an intratumoral hotspot field using Image Scope software. The 
green square lines on the left panels represent the 1 mm² hotspot demarcation. The green areas on the right panels represent the con-
sidered area for each method (UA: the whole hotspot area; SA: only the tumor area). The software was performed and the strongly 
positive pixel cells were computed.
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The density of DCs was then calculated using the for-
mula n/DA, where n is the number of positive DCs and 
DA is the demarcated area (mm²) of each hotspot.
The data analysis was generated using SAS software 
(The SAS System, 9.4. SAS Institute Inc., Cary, NC, 
USA, 2012. The normality of the residues was evalu-
ated by the Shapiro-Wilk test and the asymmetry and 
kurtosis coefficients. Parametric techniques were 
adopted for variables adherent to Gaussian distribu-
tion and nonparametric techniques when the adher-
ence was not satisfactory. The Mann-Whitney U test 
was used to verify the influence of the quantification 
methods on the positive cell counting according to the 
evaluated regions (total, intratumoral or peritumoral). 
Then, mixed linear generalized models of analysis of 
variance (ANOVA) were adjusted to test the effects 
of tumour location, tumour stage, histological grade, 
and amount of inflammation on positive cell counting. 
Multiple comparisons of averages based on Student’s 
t-test was done. The significance level was fixed at 5% 
for all statistical tests.
Results
A total of 26 cases of HIV-positive patients were 
selected. The summary of the clinicopathological 
data is presented in Table 1. A total of 624 positive 
pixel count analyses were performed. All the pro-
teins markers tested (CD1a, CD83, and CD207) were 
present in the DCs membranes of the SCC samples. 
The average of the demarcated areas (DA) for the 
SA method group analyses was 0.60 mm² ±0.23 mm² 
(mean ±standard deviation) for the intratumoral re-
gions, and 0.21 mm² ±0.13 mm² for the peritumoral 
regions analyses. The quantification method affected 
the positive cells counting independently of the eval-
uated region (total, intratumoral, and peritumoral 
analysis; P<0.05; Fig. 2).
 n %
Age (years)
















SCC, Squamous cell carcinoma. NA, Information not available.
Fig. 2: Positive cell counting distribution according to the quantification method (UA or SA) and the evaluated region (total, intratumoral, and 
peritumoral). Groups connected by lines presents differences between them (Mann-Whitney U test, P<0.05).
Table 1: Distribution of patients according to age, gender, tumour 
location, and tumour stage.
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The average positive cell counting values for all cases 
analysed in the intratumoral regions stained by CD1a 
were 57.66 for the SA method and 35.59 for the UA 
method; for CD83, the values were 8.25 cells (SA) 
and 5.54 cells (UA), and for CD207, the values were 
25.41 (SA) and 16.70 (UA). Regarding the peritumoral 
regions, the average positive cell counting stained by 
CD1a were 83.40 (SA) and 19.38 (UA); for CD83, the 
values were 81.79 cells (SA) and 13.71 cells (UA); and 
for CD207, the average number of cells were 45.29 
(SA) and 8.11 (UA).
The tumour location did not affect the positive DCs 
counting for any marker, independent of the quantifi-
cation method (Table 2). Despite the statistics results, 
the lip located cases presented a higher density of pos-
itive DCs in the peritumoral regions, compared with 
the other locations (P>0.05). Different from the CD1a 
and CD207 markers, a higher number of CD83+ cells 
can be noticed in the peritumoral regions compared 
to the intratumoral regions. There was no positivity 
for CD83 in tumors located on the palate.
The tumour stage did not affect the positive DCs 
counting (P>0.05). However, a decreased of the DCs 
general values was observed according to the advance 
of the tumor stage (Table 3). Although no significant 
statistical differences were presented, some border-
lines results are important to note. A decreasing of 
peritumoral CD1a+ cells were observed in advanced 
tumours stages (stage III/IV) (P=0.0901, SA meth-
od; P=0.0627, UA method). The same was observed 
for the peritumoral CD207+ cells; however, a rele-
vant difference can be observed between the quan-
tification methods P values (P=0.0583, SA method; 
P=0.7068, UA method).
Fifty-four percent of the patients (14 cases) had their 
SCCs classified histologically as well/moderately dif-
ferentiated, whereas 46% (12 cases) were classified as 
poorly differentiated. The histological tumour grade 
affected only the intratumoral CD1a+ cells count-
ing for both quantification method (P=0.0258, SA 
method; P=0.0340, UA method), and the peritumoral 
CD1a+ cells counting for UA method (P=0.0232; 
Table 4). For peritumoral CD1a+ cells, the number 
of positive DCs decreased in poorly differentiated 
tumours using the SA method, and the opposite hap-
pened with the use of the UA method.  In general, the 
CD83 expression was more expressive in the peritu-
moral regions.
As expected, the positivity of DCs was higher in 
SCCs that presented prominent inflammation (Table 
4). These results only were not significant for peritu-
moral CD83+ cells and intratumoral CD207+ cells. 
Regarding the quantification methods, differences 
were noted in 3 regions corresponding to the 3 differ-
ent markers (intratumoral CD1a, intratumoral CD83, 
























































Palate 38.69  ±39.91













































































Palate 20.50  ±26.87



































Table 2: Mean ±standard deviation of positive cell counting according to the tumour location, quantification method (SA or UA) and the markers 
(CD1a, CD83, and CD207). P values obtained from ANOVA comparing the effect of tumour location (P-value<0.05; Student t-test).
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III/IV 60.60  ±94.90









































*P values obtained by ANOVA-R followed by t-test applied on ranks.
Table 3: Mean ±standard deviation of positive cell counting according to the tumour stage (I/II and III/IV), the quantification method (SA or UA), 
and the markers (CD1a, CD83, and CD207). P values obtained from ANOVA comparing the effect of tumour stage (P-value<0.05; Student t-test).
Table 4: Mean ±standard deviation of positive cell counting according to the histological tumour grade and amount of inflammation, the quantifica-
tion method (SA or UA), and the markers (CD1a, CD83, and CD207). P values obtained from ANOVA comparing the effect of histological grade 
and amount of inflammation (P-value<0.05; Student t-test).
Discussion
This study focused on evaluate a novel DCs quantifi-
cation method in SCC, and compare it with a conven-
tional method. The findings showed that the positive 
cell quantification method influences the DCs density 
results and affected the DCs counting independently of 
the evaluated region. Unlike the conventional method 
(UA method), the novel SA method avoids non-target 
areas included in the hotspots improving the reliability 
and reproducibility of the cell quantification.
The cell quantification methods in the literature are het-
erogeneous in several aspects: the evaluation of differ-
ent numbers of sequential/randomly fields (23,24,27-29) 
or the selection of positive cells hotspots (25); the use 
of different magnifications as counting areas (28,29) or 
the use of previously stipulated areas size (23,25); the 
use of the total number of cells (24,29) or the average of 
the evaluated fields (25). In addition, some studies that 





























































































































































*P values obtained by ANOVA-R followed by t-test applied on ranks.
square for the counting aid (23,27). Also, there are stud-
ies that did not clearly mention how the counting was 
performed (28,29). Despite the different available meth-
ods, the use of a stipulated number of hotspots and the 
average of the evaluated fields can reduce the influence 
of the tissue size variation present in the slides.
The use of digital quantification methods has been re-
placing the old manual methods, and they presumably 
would allow standardization of cell counting results. 
Therefore, the present study compared two different 
digital quantification methods (UA and SA methods) 
based on a technique variation and, evaluating the posi-
tive cell counting averages and P values presented in 
all tables, it is possible to verify a difference between 
them. Furthermore, the present study showed contra-
dictory results between the methods applied regarding 
the histologic tumour grade (Table 4). Herein, the SA 
method showed a decreasing positive DCs number in 
poorly differentiated tumours for peritumoral CD1a+ 
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patients could lead to interesting results regarding the 
better understanding of the HIV-positive patients with 
HNC.
The limitations of the present study include the limited 
amount of cases retrieved and the restricted access to pa-
tients’ information due to the lack of standardized med-
ical records and pathological reports. Also, regardless 
of the use of digital tools, a subjective aspect inherent 
to the methods always will be present, which reinforces 
the importance that analyses should be performed by 
an experienced pathologist. The main difficulty in the 
dendritic cell quantification is that the dendrites can 
represent single or various cells, depending on the tis-
sue structure and slice width. Thus, despite the amount 
and diversity of studies present in the literature, there 
is no gold-assay regarding the positive cell quantifica-
tion system. However, the authors believe that follow-
ing the methodology presented and discussed above, the 
reliability and reproducibility of the DCs quantification 
will significantly improve.
There is a heterogeneity of the quantification methods 
presented in the literature, including the studies that 
evaluate the density of DCs (19,22-25,27-29).  Since we 
have shown that the quantification method can affect 
the research results and may lead to the acceptance or 
not of their significance, the necessity of a cell counting 
methodology with higher reliability is enforced. Hence, 
we encourage the use of the presented method idea (SA 
method) for any positive cell type counting, which also 
could facilitate the use of results as a reference for fu-
ture studies.
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